Carbasalate calcium
Chemical compound
- B01AC08 (WHO) N02BA15 (WHO)
- 5749-67-7
- 21975
- 20651
- N667F17JP1
- DTXSID90206099
Carbasalate calcium is an analgesic, antipyretic, and anti-inflammatory drug,[1] as well as a platelet aggregation inhibitor.[2] It is a chelate of calcium acetylsalicylate (the calcium salt of aspirin) and urea.[1]
References
- ^ a b Murray FE, Hudson N, Atherton JC, Cole AT, Scheck F, Hawkey CJ (January 1996). "Comparison of effects of calcium carbasalate and aspirin on gastroduodenal mucosal damage in human volunteers". Gut. 38 (1): 11–4. doi:10.1136/gut.38.1.11. PMC 1382971. PMID 8566836.
- ^ Mathieu P, Villemot JP, Stoltz JF, Scheck F, Garnier LF (June 1996). "[Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study]". Pathologie-Biologie. 44 (6): 571–80. PMID 8977914.
- v
- t
- e
Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)
Glycoprotein IIb/IIIa inhibitors |
|
---|---|
ADP receptor/P2Y12 inhibitors | |
Prostaglandin analogue (PGI2) | |
COX inhibitors |
|
Thromboxane inhibitors | |
Phosphodiesterase inhibitors | |
Other |
Vitamin K antagonists (inhibit II, VII, IX, X) | |||||
---|---|---|---|---|---|
Factor Xa inhibitors (with some II inhibition) |
| ||||
Direct thrombin (IIa) inhibitors |
| ||||
Other |
fibrinolytics
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e